Skip to main content
SpringerLink
Log in

Struvite Stones

  • Chapter
Urinary Stone Disease

Part of the book series: Current Clinical Urology ((CCU))

Abstract

The occurrence of urinary infection in patients with nephrolithiasis is not uncommon. Although stones of any composition may occur in patients who experience urinary tract infections owing to a variety of urinary pathogens, the term“infection stone” is reserved for calculi that form as a direct consequence of infection with urease-producing bacteria and the urinary environment they promote. This chapter will focus on current concepts regarding infection stones, including their pathogenesis, clinical diagnosis and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Griffith DP. Struvite stones. 1978; Kidney Int13: 372.

    Article  PubMed  CAS  Google Scholar 

  2. Griffith DP, Osborne CA. Infection (urease) stones. Miner Electrolyte Metab 1987; 13: 278.

    PubMed  CAS  Google Scholar 

  3. Gleeson MJ, Kobashi K, Griffith DP. Noncalcium nephrolithiasis. Disorders of Bone and Mineral Metabolism, (Coe FI, Favus MJ, eds.). Raven, New York, NY, 1992; p. 801.

    Google Scholar 

  4. Wong HY, Riedl CR, Griffith DP. Medical Management and Prevention of Struvite Stones. Kidney Stones: Medical and Surgical Management. Lippincott-Raven, Philadelphia, PA, 1996.

    Google Scholar 

  5. Elliot JS, Sharp RF, Lewis L. J Urol 1959; 81: 366–368.

    PubMed  CAS  Google Scholar 

  6. Griffith DP, Musher DM, Itin, C. Urease. The primary cause of infection-induced urinary stones. Invest Urol 1976; 13:346.

    PubMed  CAS  Google Scholar 

  7. Wang LP, Wong HY, Griffith DP. Treatment options in struvite stones. Urol Clin North Am 1997; 24: 149.

    Article  PubMed  CAS  Google Scholar 

  8. Silverman DE, Stamey TA. Management of infection stones: the Stanford experience. Medicine (Baltimore) 1983; 62: 44.

    CAS  Google Scholar 

  9. Peacock M, Robertson WC. The Biochemical Aetiology of Renal Lithiasis. Urinary Calculous Disease, (Wickham JEA, ed.). Churchill Livingstone, Edinburgh, 1979; p. 69.

    Google Scholar 

  10. Rodman J S. Struvite stones. Nephron 81 Suppl 1999; 1: 50.

    Google Scholar 

  11. Sarmina I, Spirnak JP, Resnick MI. Urinary lithiasis in the black population: an epidemiological study and review of the literature. J Urol 1987; 138: 14.

    PubMed  CAS  Google Scholar 

  12. Resnick MI. Evaluation and management of infection stones. Urol Clin North Am 1981; 8: 265.

    PubMed  CAS  Google Scholar 

  13. Kohri K, Ishikawa Y, Katoh Y, et al. Epidemiology of urolithiasis in the elderly. Int Urol Nephrol 1991; 23: 413.

    Article  PubMed  CAS  Google Scholar 

  14. De Vivo MJ, Fine PR, Cutter GR, Maetz HM. The risk of renal calculi in spinal cord injury patients. J Urol 1984; 131:857.

    Google Scholar 

  15. Gettman MT, Segura J W. Struvite stones: diagnosis and current treatment concepts. J Endourol 1999; 13: 653.

    PubMed  CAS  Google Scholar 

  16. Rous, S. N. and Turner, W. R.: Retrospective study of 95 patients with staghorn calculus disease. J Urol, 1977; 118:902.

    PubMed  CAS  Google Scholar 

  17. Vargas AD, Bragin SD, Mendez R. Staghorn calculis: its clinical presentation, complications and management. J Urol 1982; 127: 860.

    PubMed  CAS  Google Scholar 

  18. Wasserstein AG. Nephrolithiasis: acute management and prevention. Dis Mon 1998; 44: 196.

    Article  PubMed  CAS  Google Scholar 

  19. Grenabo L, Claes G, Hedelin H, Pettersson S. Rapidly recurrent renal calculi caused by Ureaplasma urealyticum: a case report. J Urol 1986; 135: 995.

    PubMed  CAS  Google Scholar 

  20. Rose GA, Rosenbaum TP. Recurrent infection stones with apparently negative cultures. The case for blind antibacterial treatment. Br J Urol 1992; 69: 234.

    PubMed  CAS  Google Scholar 

  21. Segura JW. Staghorn calculi. Urol Clin North Am 1997; 24: 71.

    Article  PubMed  CAS  Google Scholar 

  22. Liberman SN, Halpern EJ, Sullivan K, Bagley DH. Spiral computed tomography for staghorn calculi. Urology 1997; 50: 519.

    Article  PubMed  CAS  Google Scholar 

  23. Mostafavi MR, Ernst RD, Saltzman B. Accurate determination of chemical composition of urinary calculi by spiral computerized tomography. J Urol 1998; 159: 673.

    Article  PubMed  CAS  Google Scholar 

  24. Shorr E. The possible usefulness of estrogens and aluminum hydroxide gels in the management of renal stone. J Urol 1945; 53: 507.

    CAS  Google Scholar 

  25. Shorr E, Carter AC. Aluminum gels in the management of renal phosphatic calculi. JAMA 1950; 144: 1549.

    CAS  Google Scholar 

  26. Lavengood RW Jr, Marshall VF. The prevention of renal phosphatic calculi in the presence of infection by the Shorr regimen. J Urol 1972; 108: 368.

    PubMed  Google Scholar 

  27. McCarrison R. Causation of stone in India. BMJ 1931; 1: 1009.

    Google Scholar 

  28. Higgins CC. Urinary lithiasis: experimental production and solution with clinical application and end results. J Urol; 36: 168.

    Google Scholar 

  29. Griffith DP, Bragin S, Musher DM. Dissolution of struvite urinary stones. Experimental studies in vitro. Invest Urol 1976; 13: 351.

    PubMed  CAS  Google Scholar 

  30. Griffith DP, Moskowitz PA, Carlton CE Jr. Adjunctive chemotherapy of infection-induced staghorn calculi. J Urol 1979; 121: 711.

    PubMed  CAS  Google Scholar 

  31. Feit RM, Fair WR. The treatment of infection stones with penicillin. J Urol 1979; 122: 592.

    PubMed  CAS  Google Scholar 

  32. Fowler JE Jr. Bacteriology of branched renal calculi and accompanying urinary tract infection. J Urol1984; 131:213.

    PubMed  Google Scholar 

  33. Cohen TD, Preminger GM. Struvite calculi. Semin Nephrol 1996; 16: 425.

    PubMed  CAS  Google Scholar 

  34. Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J. Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 1991; 146: 955.

    PubMed  CAS  Google Scholar 

  35. McAleer IM, Kaplan GW, Bradley JS, Carroll SF. Staghorn calculus endotoxin expression in sepsis. Urology 2002; 59: 601.

    Article  PubMed  Google Scholar 

  36. Griffith DP, Gleeson MJ, Lee H, Longuet R, Deman E, Earle N. Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur Urol 1991; 20: 243.

    PubMed  CAS  Google Scholar 

  37. Kobashi K, Hase J, Uehara K. Specific inhibition of urease by hydroxamic acid. Biochem Biophys Acta 1962; 65: 380.

    Article  PubMed  CAS  Google Scholar 

  38. Fishbein WN, Daly JE. Urease inhibitors for hepatic coma. II. Comparative efficacy of four lower hydroxamate homologs in vitro and in vivo. Proc Soc Exp Biol Med 1970; 134: 1083.

    PubMed  CAS  Google Scholar 

  39. Hase J, Kobashi K, Kawaguchi N, Sakamoto K. Antimicrobial activity of hydroxamic acids. Chem Pharm Bull (Tokyo) 1971; 19: 363.

    CAS  Google Scholar 

  40. Dixon NE, Gazzola C, Watters JJ, Blakely RL, Zerner B. Inhibition of Jack Bean urease (EC 3.5.1.5) by acetohydroxamic acid and by phosphoramidate. An equivalent weight for urease. J Am Chem Soc 1975; 97: 4130.

    Article  PubMed  CAS  Google Scholar 

  41. Kobashi K, Takebe S, Numata A. Specific inhibition of urease by N-acylphosphoric triamides. J Biochem (Tokyo) 1985; 98: 1681.

    CAS  Google Scholar 

  42. Fishbein WM, Carbone PP. Urease Catalysis: II. Inhibition of the enzyme by hydroxyurea, hydroxylamine, and acetohydroxamic acid. J Biol Chem 1965; 240: 2407.

    PubMed  CAS  Google Scholar 

  43. Fishbein WN, Winter TS, Davidson JD. Urease Catalysis: I. Stoichiometery, Specificity, and Kinetics of a second substrate: Hydroxyurea. J Biol Chem 1965; 240: 202.

    Google Scholar 

  44. Griffith DP, Moskowitz PA, Carlton CE Jr. Adjunctive chemotherapy of infection-induced staghorn calculi. J Urol 1979; 121: 711.

    PubMed  CAS  Google Scholar 

  45. Martelli A, Buli P, Cortecchia V. Urease inhibitor therapy in infected renal stones. Eur Urol 1981; 7: 291.

    PubMed  CAS  Google Scholar 

  46. Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med 1984; 311: 760.

    Article  PubMed  CAS  Google Scholar 

  47. Putcha L, Griffith DP, Feldman S. Disposition of MC-acetohydroxamic acid and 14C-acetamide in the rat. Drug Metab Dispos 1984; 12: 438.

    PubMed  CAS  Google Scholar 

  48. Putcha L, Griffith DP, Feldman S. Pharmacokinetics of acetohydroxamic acid in patients with staghorn renal calculi. Eur J Clin Pharmacol 1985; 28: 439.

    Article  PubMed  CAS  Google Scholar 

  49. Bailie NC, Osborne CA, Leininger JR, et al. Teratogenic effect of acetohydroxamic acid in clinically normal beagles. Am J Vet Res 1986; 47: 2604.

    PubMed  CAS  Google Scholar 

  50. Rosenstein I. Therapeutic applications of urease inhibitors. J Antimicrob Chemother 1982; 10: 159.

    Article  PubMed  CAS  Google Scholar 

  51. Traxer O, Adams-Huet B, Pak CYC, Pearle MS. Risk of calcium oxalate stone formation with ascorbic acid ingestion (abstract). J Urol 2001; 165: 243.

    Article  Google Scholar 

  52. Rector FC, Scidin DW, Copenhaver JH. The mechanism of ammonia excretion during ammonium chloride acidosis. J Clin Invest 1955; 34: 20.

    PubMed  CAS  Google Scholar 

  53. Pizzarelli F, Peacock M. Effect of chronic administration of ammonium sulfate on phosphatic stone recurrence. Nephron 1987; 46: 247.

    PubMed  CAS  Google Scholar 

  54. Rodman JS, Vaughn JED. Chemolysis of urinary calculi. AUA Update Series 1992; 11:1.

    Google Scholar 

  55. Hellstrom J. The significance of staphylococci in the development and treatment of renal and ureteric stones. Br J Urol 1938; 10: 348.

    Google Scholar 

  56. Albright F, Sulkowitch HWCR. Nonsurgical aspects of the kidney stone problem. JAMA 1939; 113:2049.

    CAS  Google Scholar 

  57. Suby HI, Albright F. Dissolution of phosphatic urinary calculi by the retrograde introduction of citrate solution containing magnesium. N Engl J Med 1943; 228: 81.

    Article  Google Scholar 

  58. Mulvaney WP. A new solvent for certain urinary calculi: a preliminary report. J Urol 1959; 82: 546.

    PubMed  CAS  Google Scholar 

  59. Kohler FP. Renacidin and tissue reaction. J Urol 1962; 87: 102.

    PubMed  CAS  Google Scholar 

  60. Fostvedt GA, Barnes RW. Complications during lavage therapy for renal calculi. J Urol 1963; 80: 329.

    Google Scholar 

  61. Nemoy NJ, Staney TA. Surgical, bacteriological, and biochemical management of“infection stones”. JAMA 1971; 215: 1470.

    Article  PubMed  CAS  Google Scholar 

  62. Joshi HB, Kumar PV, Timoney AG. Citric acid (solution R) irrigation in the treatment of refractory infection (struvite) stone disease: is it useful? Eur Urol 2001, 39: 586.

    Article  PubMed  CAS  Google Scholar 

  63. Tiselius HG, Hellgren E, Andersson A, Borrud-Ohlsson A, Eriksson I. Minimally invasive treatment of infection staghorn stones with shock wave lithotripsy and chemolysis. Scand J Urol Nephrol 1999; 33: 286.

    Article  PubMed  CAS  Google Scholar 

  64. Libertino JA, Newman HR, Lytton B, Weiss RM. Staghorn calculi in solitary kidneys. J Urol 1971; 105: 753.

    PubMed  CAS  Google Scholar 

  65. Priestly JT, Dunn JH. Branched renal calculi. J Urol 1949; 61: 194.

    Google Scholar 

  66. Blandy JP, Singh M. The case for a more aggressive approach to staghorn stones. J Urol 1976; 115: 505.

    PubMed  CAS  Google Scholar 

  67. Segura JW, Preminger GM, Assimos DG, et al. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol 1994; 151: 1648.

    PubMed  CAS  Google Scholar 

  68. Snyder JA, Smith AD. Staghorn calculi: percutaneous extraction versus anatrophic nephrolithotomy. J Urol 1986; 136:351.

    PubMed  CAS  Google Scholar 

  69. Patterson DE, Segura JW, LeRoy AJ. Long-term follow-up of patients treated by percutaneous ultrasonic lithotripsy for struvite staghorn calculi. J Endourol 1987; 1: 177.

    Article  Google Scholar 

  70. Beck EM, Riehle RA Jr. The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones. J Urol 1991; 145: 6; discussion 9–10.

    PubMed  CAS  Google Scholar 

  71. Michaels EK, Fowler JE Jr. Extracorporeal shock wave lithotripsy for struvite renal calculi: prospective study with extended foliowup. J Urol 1991; 146: 728.

    PubMed  CAS  Google Scholar 

  72. Schulze H, Hertle L, Kutta A, Graff J, Senge, T. Critical evaluation of treatment of staghorn calculi by percutaneous nephrolithotomy and extracorporeal shock wave lithotripsy. J Urol 1989; 141: 822.

    PubMed  CAS  Google Scholar 

  73. Streem SB, Yost A, Dolmatch B. Combination“sandwich” therapy for extensive renal calculi in 100 consecutive patients: immediate, long-term and stratified results from a 10-year experience. J Urol 1997; 158: 342.

    Article  PubMed  CAS  Google Scholar 

  74. Meretyk S, Gofrit ON, Gafni O, et al. Complete staghorn calculi: random prospective comparison between extracorporeal shock wave lithotripsy monotherapy and combined with percutaneous nephrostolithotomy. J Urol 1997; 157: 780.

    Article  PubMed  CAS  Google Scholar 

  75. Lam HS, Lingeman JE, Mosbaugh PG, et al. Evolution of the technique of combination therapy for staghorn calculi: a decreasing role for extracorporeal shock wave lithotripsy. J Urol 1992; 148: 1058.

    PubMed  CAS  Google Scholar 

  76. Aso Y, Ohta N, Nakano M, Ohtawara Y, Tajima A, Kawabe K. Treatment of staghorn calculi by fiberoptic transurethral nephrolithotripsy. J Urol 1990; 144: 17.

    PubMed  CAS  Google Scholar 

  77. Grasso M, Conlin M, Bagley D. Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor Staghorn calculi. J Urol 1998; 160: 346.

    Article  PubMed  CAS  Google Scholar 

  78. El-Anany FG, Hammouda HM, Maghraby HA, Elakkad MA. Retrograde ureteropyeloscopic holmium laser lithotripsy for large renal calculi. BJU Int 2001; 88: 850.

    Article  PubMed  CAS  Google Scholar 

  79. Pode D, Lenkovsky Z, Shapiro A, Pfau A. Can extracorporeal shock wave lithotripsy eradicate persistent urinary infection associated with infected stones? J Urol 1988; 140: 257.

    PubMed  CAS  Google Scholar 

  80. Streem SB. Long-term incidence and risk factors for recurrent stones following percutaneous nephrostolithotomy or percutaneous nephrostolithotomy/extracorporeal shock wave lithotripsy for infection related calculi. J Urol 1995; 153: 584.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. D. Brooke Johnson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margaret S. Pearle MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, University of California, San Francisco, School of Medicine, San Francisco, CA

    Marshall L. Stoller MD  & Maxwell V. Meng MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this chapter

Cite this chapter

Johnson, D.B., Pearle, M.S. (2007). Struvite Stones. In: Stoller, M.L., Meng, M.V. (eds) Urinary Stone Disease. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-59259-972-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-972-1_17

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-219-3

  • Online ISBN: 978-1-59259-972-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation